Chun-Han Chen
7PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Aug 15, 2025
Abemaciclib impairs glioblastoma sphere formation by targeting the GSK3β-mediated transcriptional regulation of CD44 and TCF7L2.Muh-Lii Liang, Chun-Han Chen, Ya-Ching Lin
|Jul 02, 2025
FGFR inhibitors promote the autophagic degradation of IFN-γ-induced PD-L1 and alleviate the PD-L1-mediated transcriptional suppression of FGFR3-TACC3 in non-muscle-invasive bladder cancer.Yu-Chen Lin, Cheng-Ying Chu, Tsung-Han Hsieh
|Dec 18, 2024
Targeting PPARγ via SIAH1/2-mediated ubiquitin-proteasomal degradation as a new therapeutic approach in luminal-type bladder cancer.Chih-Chieh Tu, Tsung-Han Hsieh, Cheng-Ying Chu
|Oct 27, 2023
Cucurbitacin E Exerts Anti-Proliferative Activity via Promoting p62-Dependent Apoptosis in Human Non-Small-Cell Lung Cancer A549 Cells.Han-Lin Hsu, Bo-Jyun Lin, Yu-Chen Lin
|Feb 24, 2023
Stellettin B Induces Cell Death in Bladder Cancer Via Activating the Autophagy/DAPK2/Apoptosis Signaling Cascade.Chun-Han Chang, Bo-Jyun Lin, Chun-Han Chen
|Dec 10, 2021
Combining an Autophagy Inhibitor, MPT0L145, with Abemaciclib Is a New Therapeutic Strategy in GBM Treatment.Tsung-Han Hsieh, Muh-Lii Liang, Jia-Huei Zheng
Pageof 2
